Back to search

Article

MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model

2024-01-29

Abstract excerpt

Genetically engineered mouse models (GEMM) have fundamentally changed how ovarian cancer etiology, early detection, and treatment is understood. However, previous GEMMs of high-grade serous ovarian cancer (HGSOC) have had to utilize genetics rarely or never found in human HGSOC to yield ovarian cancer within the lifespan of a mouse. MYC , an oncogene, is amongst the most amplified genes in HGSOC, but it has not p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec0847b4-129a-591f-aab4-799026bc12d5
DOI
10.1101/2024.01.24.576924
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse modelDOI 10.1101/2024.01.24.576924
Select a neighboring publication to make it the new centre.